Navigation Links
Mylan Launches Thiamine Hydrochloride Injection
Date:6/28/2012

PITTSBURGH, June 28, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its Mylan Institutional business has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for preservative-free Thiamine Hydrochloride Injection, 100 mg/mL, packaged in 200 mg/2 mL multiple-dose vials. This product is indicated for the treatment of thiamine deficiency.

Thiamine Hydrochloride Injection, 100 mg/mL, had U.S. sales of approximately $18.6 million for the 12 months ending March 31, 2012, according to IMS Health. Mylan is shipping this product, presented in 25-vial packs, immediately.

Currently, Mylan has 169 ANDAs pending FDA approval representing $83.9 billion in annual sales, according to IMS Health. Thirty-seven of these pending ANDAs are potential first-to-file opportunities, representing $25.6 billion in annual brand sales, for the 12 months ending Dec. 31, 2011, according to IMS Health.

Mylan is a global pharmaceutical company committed to setting new standards in health care. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service a habit, do what's right, not what's easy and impact the future through passionate global leadership. We offer a growing portfolio of more than 1,100 generic pharmaceuticals and several brand medications. In addition, we offer a wide range of antiretroviral therapies, upon which approximately one-third of HIV/AIDS patients in developing countries depend. We also operate one of the largest active pharmaceutical ingredient manufacturers and currently market products in approximately 150 countries and territories. Our workforce of more than 18,000 people is dedicated to improving the customer experience and increasing pharmaceutical access to consumers around th
'/>"/>

SOURCE Mylan Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Mylan Launches Generic Version of Zyprexa® Tablets
2. Mylan and Pfizer Announce Epinephrine Auto-injector Settlement Agreement with Teva
3. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
4. Mylan Launches Generic Lipitor® in Five European Countries
5. Mylan Launches Generic Version of Plavix® Tablets
6. Mylan Sponsors Drug Store News and Pharmacist Society to Provide a New Business Networking Platform for Pharmacy Schools and Students
7. Mylan Launches Generic Version of Viramune® Tablets
8. Mylan Launches Generic Version of Bonviva® Film Coated Tablets in the UK and Italy
9. Mylan Announces Settlement Agreement in Patent Infringement Litigation Relating to Sunovions Brovana® Product
10. Mylan Announces Settlement Agreement in Litigation Relating to its Generic Xopenex®
11. Mylan Launches Generic Version of Lipitor®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... For the past 15 years, there has been an ... U.S. alone (U.S. Census Bureau 2012). Of course, not every accident ... there are quite a few where the car occupants can get ... the seatbelt release button or occupant injury. One ... in their lifetime but may still be "lucky" enough to come ...
(Date:3/2/2015)... Following announcements from both Novartis and ... Inc. (NASDAQ:  ARRY) today announced the completion of ... Novartis.  Along with global ownership of both assets, ... million from Novartis. Ron Squarer, Chief ... the Novartis-GSK transaction, Array now owns both binimetinib ...
(Date:3/2/2015)... NEW YORK , March 2, 2015 ... HealthCare are kicking off the 2015 One ... The month-long national campaign will raise awareness and funds ... the more than one million colorectal cancer survivors living ... fight this disease with great strength and courage every ...
Breaking Medicine Technology:New SuperVizor, an Automobile Escape Tool, Ensures the Safety of Drivers and Passengers on the Road 2Array Announces Completion Of Binimetinib And Encorafenib Transactions 2Array Announces Completion Of Binimetinib And Encorafenib Transactions 3Array Announces Completion Of Binimetinib And Encorafenib Transactions 4Array Announces Completion Of Binimetinib And Encorafenib Transactions 5Advocacy Group Fight Colorectal Cancer and Bayer HealthCare Join Forces for One Million Strong 2Advocacy Group Fight Colorectal Cancer and Bayer HealthCare Join Forces for One Million Strong 3Advocacy Group Fight Colorectal Cancer and Bayer HealthCare Join Forces for One Million Strong 4Advocacy Group Fight Colorectal Cancer and Bayer HealthCare Join Forces for One Million Strong 5
... Oct. 26 Accuray,Incorporated (Nasdaq: ARAY ), ... today that the company is partnering with The ... Houston, Texas to launch a prospective,clinical study to ... in the study will be randomly assigned to ...
... announces data presented at AACR-NCI-EORTC ... ... (CTI) (Nasdaq and MTAX: CTIC) and Systems Medicine, LLC (SM), a,wholly-owned ... candidates during the 19th annual AACR-NCI-EORTC Symposium. "These studies show ...
Cached Medicine Technology:M. D. Anderson Cancer Center to Lead Study of Surgery vs. CyberKnife(R) Radiosurgery for Operable Lung Cancer Patients 2M. D. Anderson Cancer Center to Lead Study of Surgery vs. CyberKnife(R) Radiosurgery for Operable Lung Cancer Patients 3M. D. Anderson Cancer Center to Lead Study of Surgery vs. CyberKnife(R) Radiosurgery for Operable Lung Cancer Patients 4Preclinical Studies Show Potential Progress Toward Identifying Specific Tumor Types With Higher Likelihood of Demonstrating Response to Anti-Cancer Compounds Early in Clinical Development 2Preclinical Studies Show Potential Progress Toward Identifying Specific Tumor Types With Higher Likelihood of Demonstrating Response to Anti-Cancer Compounds Early in Clinical Development 3Preclinical Studies Show Potential Progress Toward Identifying Specific Tumor Types With Higher Likelihood of Demonstrating Response to Anti-Cancer Compounds Early in Clinical Development 4Preclinical Studies Show Potential Progress Toward Identifying Specific Tumor Types With Higher Likelihood of Demonstrating Response to Anti-Cancer Compounds Early in Clinical Development 5
(Date:3/2/2015)... Portland, OR (PRWEB) March 02, 2015 ... its plan to remake American healthcare. Zoom will ... include 28 neighborhood clinics and advanced care studios ... mental health, emergency services, specialty care and outpatient ... provide on-demand access to almost all healthcare needs ...
(Date:3/2/2015)... 2015 Burns Engineering's Lab-to-Lab Calibration ... Secondary Standard Platinum Resistance Thermometers (SSPRTs) and industrial ... or less . . . guaranteed. ... (Lab Code 200706-0), ISO 9001 and 17025 Certified ... is -196°C to 500°C, both ITS-90 and Callendar-van ...
(Date:3/2/2015)... 2015 Representatives with BNatrl ( ... launched a multivitamin supplement that’s specifically designed for ... for BNatrl, said the multivitamin, which launched Jan. ... other world-class athletes. , "Being an avid marathon ... whole food multivitamin to improve my performance,” said ...
(Date:3/2/2015)... Houston, TX (PRWEB) March 02, 2015 ... a lot easier thanks to the success of ... making meal planning easy and delicious for thousands ... overwhelmingly positive customer feedback by expanding to offer ... Traditional Tastes, which features seasonally appropriate classic recipes ...
(Date:3/2/2015)... A true renaissance man—some might call him a “Jack ... band Khazad Doom, has long inspired his countless fans. That ... odds. His motto throughout his life has always been “Got ... before him. And that attitude, born amidst the turmoil and ... a new generation. , As Eadon knows, when you have ...
Breaking Medicine News(10 mins):Health News:ZoomCare Announces 28-Location, On-Demand Neighborhood Health Campus 2Health News:ZoomCare Announces 28-Location, On-Demand Neighborhood Health Campus 3Health News:Burns Engineering Announces Quick-Turn Temperature Calibrations 2Health News:Bnatrl Launches Multivitamin Supplement for Runners 2Health News:DinnerDork Announces New Meal Planning Support for the Home Cook 2Health News:DinnerDork Announces New Meal Planning Support for the Home Cook 3Health News:Cult Rock Star’s “Got To Make It” Attitude Inspires New Generations 2Health News:Cult Rock Star’s “Got To Make It” Attitude Inspires New Generations 3
... tricked body, slowed down metabolism in rats , , MONDAY, ... popular artificial sweetener has the unexpected and unwelcome effect ... that saccharin altered the ability of rats to control ... trade group scoffed at the findings, saying they don,t ...
... Progress in Women,s Cancer, Theme, Spotlights Four ... Cancers, CHICAGO, Feb. 11 The Society ... Meeting on Women,s Cancer March,9-12 at the Tampa ... will feature more than 350 scientific presentations,lectures, workshops, ...
... ... ... ... Tuesday, February 12, 2008, The,James E. Marshall OCD Foundation, which benefits genetic research and,awareness for Obsessive-Compulsive Disorder, will ...
... identified a key protein target that may be a crucial ... new therapies to treat pneumonia, the leading killer of children ... of the Division of Pediatric Pulmonary Medicine, Allergy and Immunology ... a protein known as interleukin 22 (IL-22) in the immune ...
... German . , Anyone trying to build sandcastles ... and imagination, but not an instruction manual. The water ... of the sand. This observation, which is borne out ... with water content of just 3%, the fluid inside ...
... Directions, Inc. (MDI),an independent digital medical education and ... program dealing with the,management of chronic pain has ... lectures by national experts., The study, which ... and Stroke (NINDS), was reported February 5, 2008 ...
Cached Medicine News:Health News:Sugar Substitutes May Contribute to Weight Gain 2Health News:Sugar Substitutes May Contribute to Weight Gain 3Health News:Society of Gynecologic Oncologists to Host 39th Annual Meeting on Women's Cancer 2Health News:Society of Gynecologic Oncologists to Host 39th Annual Meeting on Women's Cancer 3Health News:Fourth Annual James E. Marshall OCD Foundation Beyond Beauty Dinner to Honor E. Scott Beattie, Chairman and CEO, Elizabeth Arden, Inc. and Charles H. Townsend, President and CEO, Conde Nast Publications 2Health News:Children's Hospital scientists identify possible target for prevention and treatment of pneumonia 2Health News:Why anyone can make a sandcastle 2Health News:Inexpensive Online Pain Education Program for Physicians as Effective as Live Presentations by National Experts 2
2.0mm Rounded Tip, 12mm From Tip to Bend Gently Curved, 15mm Shaft; In Titanium...
0.5X2.0mm Tip, Oval Shape; in Titanium....
Bend with "H" Shaped Tip, LEFT; in Titanium....
Lightly Curved-Blunt Tips Rounded Blades; 1mm Eye in Blades; 27mm from mid screw to tip. Matte finish; Stainless Steel, overall length 120mm...
Medicine Products: